Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced that, following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has granted the marketing authorization for the veterinary medicinal product PANACUR
AquaSol (fenbendazole 200 mg/mL) for use in chickens.
PANACUR
AquaSol is a highly stable, farm-friendly, water-administered suspension product produced with an innovative wet-milling technology. It is currently available in the EEA for use in swine.
“We are very pleased that the European Commission has approved PANACUR
AquaSol for chickens,” stated Fabio Paganini, Associate Vice President, Merck Animal Health. “PANACUR
has a long history of proven results as a leading dewormer and we are excited to bring this option for convenient water administration to chicken farmers throughout the EEA.”
Approved indication:
PANACUR
AquaSol will be indicated for the treatment of gastro-intestinal nematodes in chickens infected with:
- Ascaridia galli (L5 and adult stages)
- Heterakis gallinarum (L5 and adult stages)
Through the company’s proprietary wet-milling technology, PANACUR
AquaSol is a highly stable suspension which, as a result of smaller more uniform particle size, does not require frequent agitation and provides both a high level of efficacy and convenience.
PANACUR
AquaSol has been proven safe for all types of chickens, including layers, broilers and breeders.
It has a zero day withdrawal period for eggs and a six day withdrawal period for meat and offal.